Top Institutions in Addiction Psychiatry
Leading institutions in addiction psychiatry and substance use disorder research typically conduct randomized controlled trials, longitudinal cohort studies, and translational research to evaluate pharmacotherapies and behavioral interventions for stimulant use disorders.
-
#1
University of New South Wales
Sydney, NSW
Home institution of the lead study author, with strong expertise in methamphetamine use disorder and clinical trials evaluating pharmacological treatments for stimulant addiction.
Key Differentiators
- Addiction Psychiatry
- Substance Use Disorder Research
-
#2
Johns Hopkins University
Baltimore, MD
Renowned for pioneering research in addiction medicine and clinical trials targeting stimulant use disorders, including pharmacotherapy development.
Key Differentiators
- Addiction Psychiatry
- Clinical Pharmacology
-
#3
Columbia University Irving Medical Center
New York, NY
Leads multiple clinical trials and translational research projects on substance use disorders, including methamphetamine and other stimulant addictions.
Key Differentiators
- Addiction Psychiatry
- Behavioral Health Research
-
#4
University of California, San Francisco
San Francisco, CA
Strong focus on clinical research in substance use disorders with expertise in conducting outpatient pharmacotherapy trials for stimulant addiction.
Key Differentiators
- Addiction Medicine
- Clinical Trials
-
#5
National Institute on Drug Abuse (NIDA)
Bethesda, MD
Primary federal agency supporting and conducting research on drug abuse and addiction, including stimulant use disorder pharmacotherapies.
Key Differentiators
- Addiction Research
- Pharmacotherapy Development
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
